Geode Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Buy |
|
|||||
|
2025
Q1 | $546K | Buy |
|
|||||
|
2024
Q4 | $840K | Buy |
|
|||||
|
2024
Q3 | $948K | Buy |
|
|||||
|
2024
Q2 | $939K | Buy |
|
|||||
|
2024
Q1 | $1.64M | Buy |
|
|||||
|
2023
Q4 | $1.09M | Buy |
|
|||||
|
2023
Q3 | $873K | Buy |
|
|||||
|
2023
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q1 | $970K | Buy |
|
|||||
|
2022
Q4 | $964K | Buy |
|
|||||
|
2022
Q3 | $851K | Buy |
|
|||||
|
2022
Q2 | $1.07M | Sell |
|
|||||
|
2022
Q1 | $2.8M | Sell |
|
|||||
|
2021
Q4 | $5.08M | Buy |
|
|||||
|
2021
Q3 | $5.72M | Sell |
|
|||||
|
2021
Q2 | $7.3M | Buy |
|
|||||
|
2021
Q1 | $8.33M | Buy |
|
|||||
|
2020
Q4 | $4.97M | Buy |
|
|||||
|
2020
Q3 | $5.01M | Buy |
|
|||||
|
2020
Q2 | $5.91M | Buy |
|
|||||
|
2020
Q1 | $5.41M | Buy |
|
|||||
|
2019
Q4 | $5.45M | Buy |
|
|||||
|
2019
Q3 | $4.55M | Buy |
|
|||||
|
2019
Q2 | $6.72M | Buy |
|
|||||
|
2019
Q1 | $6.42M | Buy |
|
|||||
|
2018
Q4 | $8.56M | Buy |
|
|||||
|
2018
Q3 | $9.51M | Buy |
|
|||||
|
2018
Q2 | $8.3M | Buy |
|
|||||
|
2018
Q1 | $9.39M | Sell |
|
|||||
|
2017
Q4 | $7.33M | Buy |
|
|||||
|
2017
Q3 | $5.92M | Buy |
|
|||||
|
2017
Q2 | $3.64M | Buy |
|
|||||
|
2017
Q1 | $3.6M | Buy |
|
|||||
|
2016
Q4 | $2.11M | Buy |
|
|||||
|
2016
Q3 | $2.83M | Buy |
|
|||||
|
2016
Q2 | $777K | Buy |
|
|||||
|
2016
Q1 | $880 | Buy |
|
|||||
|
2015
Q4 | $1.21M | Buy |
|